Cargando…
Commentary: “Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer”
The major theme throughout this paper was solving the problem of multidrug resistance (MDR) in chemotherapeutic remediation for breast cancer patients by an aptamer-labeled hybrid nanoparticle to enhance selective delivery of siRNA into tumor cells and produce an enhanced knock-down of P-glycoprotei...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485932/ https://www.ncbi.nlm.nih.gov/pubmed/31032482 http://dx.doi.org/10.29245/2578-2967/2018/1.1103 |